| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
in00005772039 |
| 005 |
20260327174726.9 |
| 006 |
m o d |
| 007 |
cr un|---aucuu |
| 008 |
230709s2023 enka ob 001 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e rda
|c YDX
|d OPELS
|d UKMGB
|d YDX
|d OCLCF
|d OCLCO
|d OCLCL
|d SFB
|d OCLCO
|
| 015 |
|
|
|a GBC376380
|2 bnb
|
| 016 |
7 |
|
|a 021026800
|2 Uk
|
| 020 |
|
|
|a 9780323916905
|q electronic book
|
| 020 |
|
|
|a 0323916902
|q electronic book
|
| 020 |
|
|
|z 9780323916639
|
| 020 |
|
|
|z 0323916635
|
| 035 |
|
|
|a (OCoLC)1389607751
|
| 037 |
|
|
|a 9780323916905
|b Ingram Content Group
|
| 050 |
|
4 |
|a RS201.P65
|b P65 2023
|
| 082 |
0 |
4 |
|a 615.1
|2 23/eng/20230718
|
| 049 |
|
|
|a TXAM
|
| 245 |
0 |
0 |
|a Polymer-drug conjugates :
|b linker chemistry, protocols and applications /
|c edited by Jitender Madan, Ashish Baldi, Monika Chaudhary, Neetu Chopra.
|
| 264 |
|
1 |
|a London :
|b Academic Press,
|c 2023.
|
| 300 |
|
|
|a 1 online resource (xxviii, 480 pages) :
|b illustrations (some color)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
|
|
|a Description based on online resource; title from digital title page (viewed on October 09, 2023).
|
| 505 |
0 |
|
|a Intro -- Title page -- Table of Contents -- Copyright -- Dedication -- Contributors -- Editors -- Preface -- Acknowledgment -- Chapter 1. Drug delivery: The conceptual perspectives and therapeutic applications -- 1. Introduction -- 2. Basic fundamentals of targeted drug delivery systems -- 3. Passive targeting -- 4. Active targeting -- 5. Ligands for targeting -- 6. Endocytosis -- 7. Need of targeted drug delivery system -- 8. Targeted drug delivery system by oral and parenteral routes -- 9. Regulatory challenges of novel drug delivery system -- 10. Scale-up challenges of targeted drug delivery systems -- 11. Marketed formulation based on targeted drug delivery systems -- 12. Conclusion and summary -- Chapter 2. Rational design of linkers in polymer-drug conjugates -- 1. Introduction -- 2. Polymer-drug conjugate -- 3. Linkers/spacers -- 4. Conclusion -- Chapter 3. Exploration of polymers in drug delivery: The structural and functional considerations -- 1. Introduction -- 2. Different polymers used in linker chemistry for bioconjugation of drugs -- 3. Classification of polymers on the basis of their structural and physicochemical behavior -- 4. Role and function of different polymers used in linker chemistry -- 5. Selection of polymeric drug delivery system and drug release -- 6. Some recent developments -- 7. Conclusion -- Chapter 4. Chemistry of conjugation in drug delivery: The prospects of biodegradable bonds in polymer-drug conjugates -- 1. Introduction -- 2. Characteristics of an ideal polymer -- 3. Polymer-based drug delivery system -- 4. Polymers used in preparation of polymer-drug conjugates -- 5. Drug release from polymer-drug conjugates is pH sensitive -- 6. Different linkages involved in polymer-drug conjugation -- 7. Conclusion.
|
| 505 |
8 |
|
|a Chapter 5. Polymer-drug conjugation using ester and ortho-ester bond: Mechanism, protocols, and applications -- 1. Introduction -- 2. Discovery tale of polymer-drug conjugates -- 3. Insights into ester and orthoester bond as drug-polymer conjugate strategy -- 4. Ester and orthoester bond: Chemistry and cleavage -- 5. End group functionalities of ester and orthoester conjugation: Synthetic procedures and applications -- 6. Conclusion -- Chapter 6. Polymer-drug linking through amide bonds: the chemistry and applications in drug delivery -- List of abbreviations -- 1. Introduction about polymer -- 2. Polymer-drug conjugates -- 3. Various polymer-drug linking through amide bond: its chemistry -- 4. Application of polymer-drug linking through amide bond in drug delivery -- 5. Conclusion and future aspects with polymer-drug conjugate -- Chapter 7. Drug-polymer conjugate tailoring by disulfide linkage for controlled and targeted drug delivery -- 1. Introduction -- 2. Basic chemistry of disulfide linkage -- 3. Binding with disulfide linkage -- 4. Drug delivery by drug-polymer sulfide linkage conjugates -- 5. Synthetic strategies of polymer-drug conjugates -- 6. New facile strategy -- 7. Polymer therapeutics for drug delivery -- 8. Applications of tailored drug-polymer conjugates by sulfide linkage -- 9. Failures of disulfide linkage -- 10. Successful disulfide linkages -- 11. Challenges and future projections -- Chapter 8. Thioether linkage chemistry: perspectives and prospects in therapeutic designing -- List of abbreviations -- 1. Introduction -- 2. Paclitaxel/gemcitabine -- 3. Cyclodextrin hyaluronic acid conjugates -- 4. Camptothecin-PEG-LHRH drug conjugate -- 5. BIM-23A760 -- 6. Conclusion -- Chapter 9. Drug targeting to cancer cells through stimuli-responsive imine bonds: fascinating aspects of site specificity -- 1. Introduction.
|
| 505 |
8 |
|
|a 2. Polymeric drug delivery system -- 3. Shell-sheddable nanoassemblies -- 4. Core-degradable backbone-multicleavable nanoassemblies -- 5. Core-degradable pendant-multicleavable nanoassemblies -- 6. Stimuli-responsive/pH-responsive drug-polymer conjugates for cancer chemotherapy -- 7. Mechanism of formation of imine bond -- 8. In vivo fate of pH-responsive drug-polymer conjugates with imine and hydrazone linker -- 9. Drawbacks of imine and hydrazone linker bond in development of drug-polymer conjugate -- 10. Applications -- 11. Polymeric nanoparticles -- 12. Hydrogels -- 13. Drug-polymer conjugate (polymeric prodrugs) -- 14. Polymeric micelles -- Chapter 10. Carbamate-drug conjugates in drug delivery: structural and mechanistic considerations -- 1. Introduction -- 2. Chemistry -- 3. Methodologies for carbamate bond formation -- 4. Applications of carbamates in pharmaceutical field -- Chapter 11. Bonding through phosphodiester moiety: Its implications in pharmaceutical modifications -- 1. Introduction -- 2. Phosphodiester-containing biomolecules -- 3. Chemistry of phosphodiester bond -- 4. Role of phospholipids in drug delivery -- 5. Oligonucleotide-phosphodiester conjugates -- 6. siRNA oligonucleotide conjugates -- 7. Conclusion -- Chapter 12. Enzymatically degradable linkers -- 1. Introduction -- 2. Chemotherapeutic agents and their therapeutic limitations -- 3. Concept of cancer targeted polymer-drug conjugates -- 4. Components of polymer-drug conjugates -- 5. Design and development of enzyme sensitive nanocarrier-mediated anticancer drug delivery system -- 6. Conclusion -- Chapter 13. Dendrimer-drug conjugates -- List of abbreviations -- 1. Dendrimers-based drug delivery systems -- 2. Advantages of dendrimer-drug conjugates -- 3. Prerequisites for dendrimer-drug conjugates -- 4. Synthesis strategies of dendrimer-drug conjugates.
|
| 505 |
8 |
|
|a 5. Dendrimer prodrugs with spacers -- 6. Applications of dendrimer-drug conjugates -- 7. Dendrimer-drug conjugates in cancer therapeutics -- 8. Dendrimer-drug conjugates in inflammatory diseases -- 9. Conclusion and perspective of developing dendrimer-drug conjugates -- Chapter 14. Antibody-drug conjugate: Emerging trend for targeted treatment -- 1. Introduction -- 2. Antibody-drug conjugates design and its chemistry -- 3. Conjugation mechanism -- 4. Mechanism of action -- 5. Antibody-drug conjugate strategies for treatment of diseases -- 6. Limitation and potency enhancement of antibody-drug conjugates -- 7. Clinical implication of ADC -- 8. Conclusion and future perspective -- Chapter 15. Drug-polymer conjugates: Challenges, opportunities, and future prospects in clinical trials -- 1. Introduction -- 2. Types of polymer-drug conjugates -- 3. Polymers used in PDC -- 4. Polymer protein conjugates -- 5. Preparation of PDCs -- 6. Analytical methodology -- 7. Advantages of PDC -- 8. Applications of PDC -- 9. Polymer-drug conjugates as a concept for combination therapy -- 10. Polymer conjugates for new molecular targets are being developed -- 11. Drug distribution -- 12. PDC in clinical trials -- 13. Conclusion and future prospects -- Index.
|
| 520 |
8 |
|
|a Polymer-Drug Conjugates: Linker Chemistry, Protocols and Applications discusses important concepts, fundamentals and prospective applications of 'Linker Chemistry' in a clear-and-concise manner. The book provides vital information on chemical entities binding with the drug-polymer complex for targeted drug delivery systems. It highlights roles and significance, different classes and synthetic protocols as well as mechanisms of chemical bond formation in drug-polymer conjugation in drug delivery, also offering insights into the mechanism of polymer interaction with linker and drug molecules by biodegradable chemical bonding.The protocol of binding with drug molecules is clearly explained and justified with case studies, helping researchers and advanced students in the pharmaceutical sciences understand fundamentals involved and related aspects in molecule designing for effective therapeutic benefits.Covers mechanism, protocol and therapeutic significance of Polymer-Drug ConjugatesOutlines updated methods and techniques to enumerate conjugation with related case studiesIncludes comprehensive compilation of marketed and clinical trial drugs conjugated with polymers or linkers.
|
| 650 |
|
0 |
|a Polymeric drug delivery systems.
|
| 650 |
|
0 |
|a Bioconjugates.
|
| 650 |
|
0 |
|a Pharmaceutical chemistry.
|
| 650 |
|
2 |
|a Drug Delivery Systems
|
| 650 |
|
2 |
|a Polymers
|x therapeutic use
|
| 650 |
|
2 |
|a Polymers
|x chemistry
|
| 650 |
|
2 |
|a Chemistry, Pharmaceutical
|
| 650 |
|
6 |
|a Médicaments polymères
|x Administration
|x Dispositifs.
|
| 650 |
|
6 |
|a Bioconjugués.
|
| 650 |
|
6 |
|a Chimie pharmaceutique.
|
| 650 |
|
7 |
|a Bioconjugates
|2 fast
|
| 650 |
|
7 |
|a Polymeric drug delivery systems
|2 fast
|
| 653 |
|
|
|a Pharmacology
|
| 653 |
|
|
|a Pharmaceutical Industry
|
| 653 |
|
|
|a Medical
|
| 653 |
|
|
|a Business & Economics
|
| 655 |
|
7 |
|a Electronic books.
|2 local
|
| 700 |
1 |
|
|a Madan, Jitender,
|e editor.
|
| 700 |
1 |
|
|a Baldi, Ashish,
|e editor.
|
| 700 |
1 |
|
|a Chaudhary, Monika,
|e editor.
|
| 700 |
1 |
|
|a Chopra, Neetu,
|e editor.
|
| 710 |
2 |
|
|a ScienceDirect (Online service)
|
| 776 |
0 |
8 |
|i ebook version :
|z 9780323916905
|
| 776 |
0 |
8 |
|c Original
|z 0323916635
|z 9780323916639
|w (OCoLC)1321785682
|
| 856 |
4 |
0 |
|u http://proxy.library.tamu.edu/login?url=https://www.sciencedirect.com/science/book/9780323916639
|z Connect to the full text of this electronic book
|t 0
|
| 955 |
|
|
|a Elsevier ScienceDirect 2026-2027
|
| 994 |
|
|
|a 92
|b TXA
|
| 999 |
f |
f |
|i 5beecbe2-5666-4b01-a585-537aa3adecea
|s 24448835-c62d-48c1-9509-31665d1bbaee
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|s www_evans
|d Available Online
|t 0
|e RS201.P65 P65 2023
|h Library of Congress classification
|
| 998 |
f |
f |
|a RS201.P65 P65 2023
|t 0
|l Available Online
|